Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers
- DOI
- 10.1097/mnm.0000000000002258
- Published
- 2026-11-03
- Container
- Nuclear Medicine Communications
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/mnm.0000000000002258,
title = {Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers},
author = {Filiz Hatipoglu and Ozcan Senmevsim and E. Gokhan Kahraman and Funda Tasli},
year = {2026},
journal = {Nuclear Medicine Communications},
doi = {10.1097/mnm.0000000000002258},
url = {https://doi.org/10.1097/mnm.0000000000002258}
}RIS
TY - JOUR TI - Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers AU - Filiz Hatipoglu AU - Ozcan Senmevsim AU - E. Gokhan Kahraman AU - Funda Tasli PY - 2026 JO - Nuclear Medicine Communications DO - 10.1097/mnm.0000000000002258 UR - https://doi.org/10.1097/mnm.0000000000002258 ER -
APA
Hatipoglu, F., Senmevsim, O., Kahraman, E. G., & Tasli, F. (2026). Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers. Nuclear Medicine Communications. https://doi.org/10.1097/mnm.0000000000002258
Source records
- crossref · retrieved 2026-11-11T01:04:44.847Z